E-ISSN 0976-2833 | ISSN 0975-3583
 

Original Research (Original Article) 


RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective

Aravind Kumar Subramanian, Xavier Christu Rajan.V.

Abstract
Novel Corona virus (COVID-19) caused global outbreak and affected the health of many individuals and caused millions of death worldwide. World health organisation announced this disease as pandemic virus. This disease was first reported in Hubei Province on December at Wuhan, China. Within a short span the disease spread across 177 countries across the globe and World health organisation reported 16,755,633 confirmed cases and 661244 deaths as on 29th July 2020. Respiratory illness and mild flu like symptoms are mostly common symptoms of COVID-19. It also affects the cardiovascular status especially the individual with pre-existing cardiovascular disease. Direct myocardial injury is observed and appearance of inflammation is the primary mechanism involved for Cardiac injury. This review enlightens the role of RAAS Inhibitors like ACE-Is, ARBs and statins in COVID-19 pandemic.

Key words: Novel Corona virus, COVID-19, Cardiovascular, RAAS inhibitors, Statins


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Aravind Kumar Subramanian
Articles by Xavier Christu Rajan.V
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. . 2020; 11(3): 99-100. doi:10.31838/jcdr.2020.11.03.23


Web Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. http://www.jcdronline.org//?mno=118031 [Access: August 02, 2020]. doi:10.31838/jcdr.2020.11.03.23


AMA (American Medical Association) Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. . 2020; 11(3): 99-100. doi:10.31838/jcdr.2020.11.03.23



Vancouver/ICMJE Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. . (2020), [cited August 02, 2020]; 11(3): 99-100. doi:10.31838/jcdr.2020.11.03.23



Harvard Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V (2020) RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. , 11 (3), 99-100. doi:10.31838/jcdr.2020.11.03.23



Turabian Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. 2020. RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. Journal of Cardiovascular Disease Research, 11 (3), 99-100. doi:10.31838/jcdr.2020.11.03.23



Chicago Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. "RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective." Journal of Cardiovascular Disease Research 11 (2020), 99-100. doi:10.31838/jcdr.2020.11.03.23



MLA (The Modern Language Association) Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. "RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective." Journal of Cardiovascular Disease Research 11.3 (2020), 99-100. Print. doi:10.31838/jcdr.2020.11.03.23



APA (American Psychological Association) Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V (2020) RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. Journal of Cardiovascular Disease Research, 11 (3), 99-100. doi:10.31838/jcdr.2020.11.03.23





Most Viewed Articles
  • Reduced nitrate level in individuals with hypertension and diabetes
    Shiekh Gazalla Ayub, Taha Ayub, Saquib Naveed Khan, Rubiya Dar, Khurshid Iqbal Andrabi
    . 2011; 2(3): 172-176
    » Abstract » doi: 10.4103/0975-3583.85264

  • Association of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practice
    Manuel Morgado, Sandra Rolo, Ana Filipa Macedo, Miguel Castelo-Branco
    . 2011; 2(1): 44-49
    » Abstract » doi: 10.4103/0975-3583.78596

  • Abdominal obesity, an independent cardiovascular risk factor in Indian subcontinent: A clinico epidemiological evidence summary
    D. S. Prasad, Zubair Kabir , A. K. Dash, B. C. Das
    . 2011; 2(4): 199-205
    » Abstract » doi: 10.4103/0975-3583.89803

  • Utilization of Real-time 3D Transesophageal Echocardiography in an Urban Academic Medical Center
    Lili Zhang, Elaine Y. Lin, Dron Bhandari, Mohan Pamerla, George K. Lui, Cynthia C. Taub
    . 2014; 5(2): 9-14
    » Abstract » doi: 10.5530/jcdr.2014.2.3

  • High prevalence of cardiovascular diseases among other medically compromised conditions in dental patients: A retrospective study
    Sumit Bhateja
    . 2012; 3(2): 113-116
    » Abstract » doi: 10.4103/0975-3583.95364

  • Most Downloaded
  • Review Article: Impact of Ivabradine on Cardiovascular Morbidity
    Gammone M, Riccioni G, D’Orazio
    . 2020; 11(1): 4-8
    » Abstract » doi: 10.5530/jcdr.2020.11.02

  • Vascular Endothelial Growth Factor and its Soluble Receptor-1 as Surrogate Markers for Subjects with High-risk of Cardiovascular Disease
    Vipa Boonkitticharoen, Chanika Sritara, Prin Vathesatogkit, Supakajee Saengruang-Orn,Wipa Ratanachaiwong, Piyamitr Sritara
    . 2014; 5(2): 35-42
    » Abstract » doi: 10.5530/jcdr.2014.2.8

  • Study of Metabolic Syndrome and Its Components Among Kurnool District Population of Andhra Pradesh with Different Ethnic Backgrounds
    Pandit Vinodh Bandela, Nilima Nandakumar Dongre, Jeevan Gangadhar Ambekar, Kedam Durga Prasad, Basavaraj B Devaranavadagi
    . 2017; 8(3): 83-88
    » Abstract » doi: 10.5530jcdr.2017.3.20

  • Diagnosis and surgical treatment of carotid body tumor: A report of 18 cases
    Dan Ma, Min Liu, Hua Yang, Xiaogan Ma, Chaojun Zhang
    . 2010; 1(3): 122-124
    » Abstract » doi: 10.4103/0975-3583.70905

  • P2Y receptors as regulators of lung endothelial barrier integrity
    Evgeny Zemskov, Rudolf Lucas Alexander D. Verin, Nagavedi S. Umapathy
    . 2011; 2(1): 14-22
    » Abstract » doi: 10.4103/0975-3583.78582

  • Most Cited Articles